chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within a week of the Moderna booster, I started having eye infections and dizziness. Then about three weeks later I had a sudden explosion of symptoms: extreme pain radiating from the bridge of my nose that felt like my nose breaking, intense pain and pressure in face, malar rash, rashes, spots and lumps all over skin, visual reduction, visual snow, visual disturbances, head pain and pressure, difficulty processing light and sound, whole lower half of face swelled up and has remained swollen for almost one year now, veins swelled up, muscles weakened and wasted away, exercise intolerance, lost 6-7 pounds of weight when I was already small. Entire face looks like it aged 50 years. Saggy skin everywhere hanging off my bones. Extreme insomnia, heart racing, allergies to everything, destruction of my sinuses, no energy, extreme fatigue. I have been sick for almost a year now with no improvement. My doctors recognize the vaccine caused this and have said the vaccine induced an immune reaction that they cannot figure out how to stop. I was a healthy thirty-one-year-old and now can barely function.
I came home after receiving the vaccine and fell asleep at 6 pm.  I woke up later and didn?t sleep much more overnight. By morning I had a blasting headache and my glands under my ears were very painful.  I was literally incapacitated! I was in bed all day fading in and out and unable to eat. My husband wanted to take me to the emergency room.  The headache was blinding.  By about 8 pm I started to wake up a bit and this morning I?m much better.
Pt. states that after receiving the 1st dose of Shingrix Zoster 11/29/2021, started experiencing symptoms immediately of swelling in the face with redness (subsiding with 2 hrs). 11/30/2021 started experiencing symptoms of Herpes outbreak in and along the nose/surrounding area. Primary communications 12/01/2021 (still waiting for recommendations). Still experiencing symptoms.
Fever (low grade)headache (moderate)neck ache (moderate)lower back pain (severe)welt/hive at injection site; Fever (low grade)headache (moderate)neck ache (moderate)lower back pain (severe)welt/hive at injection site; Fever (low grade)headache (moderate)neck ache (moderate)lower back pain (severe)welt/hive at injection site; Fever (low grade)headache (moderate)neck ache (moderate)lower back pain (severe)welt/hive at injection site; Fever (low grade)headache (moderate)neck ache (moderate)lower back pain (severe)welt/hive at injection site; This is a spontaneous report from a contactable other healthcare professional (patient). A 50-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EN6203, Expiry date: not reported), via intramuscular route of administration in left arm on 17Mar2021 at 15:00 (at age of 50-years-old) as single dose for covid-19 immunization at workplace clinic. The patient was not pregnant at the time of vaccination. The patient medical history was not reported. No allergies to medications, food, or other products. Concomitant medication(s) included ethinylestradiol, norethisterone acetate (JUNEL) taken for an unspecified indication, start and stop date were not reported; buspirone (BUSPIRONE) taken for an unspecified indication, start and stop date were not reported. The patient previously took first dose of bnt162b2 (COMIRNATY, Formulation: Solution for injection, Batch/Lot number: EL3247, Expiration Date: Not reported), via intramuscular route of administration in left arm on 24Feb2021 at 15:00 as dose 1, single for covid-19 immunization. The patient had not received any other vaccine within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. On 18Mar2021 at 07:00, the patient experienced fever (low grade) headache (moderate)neck ache (moderate)lower back pain (severe)welt/hive at injection site. The patient received Ibuprofen, acetaminophen, tramadol, Benadryl as treatment for the adverse event. The outcome of the event welt/hive at injection site was recovering while rest all the events recovered on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Got immediately lightheaded after covid shot. Patient was sitting in chair. Patient started to slump in chair, then I tried to catch her, but she rolled to the carpet and hit head. I lifted her feet, put jacket under head and tapped on her face until she became alert again,  30 seconds.
The afternoon after the vaccine I felt real weak, dizzy and so nauseous.  This morning and all day it has gotten worse. Can't eat anything. Juat a lingering nausea
Report 20010265341 describes Ramsay Hunt syndrome in an adult male of unspecified age who received an injection of hep B vaccine. This report was received from the vaccinee's coworker an dhas not been verified by a physician or other healthcare professional. Medical history, concurrent conditions and concurrent medications were not specified. In October 2001, the vaccinee reportedly developed facial paralysis following receipt of hep A inactivated and hep b recombinant vaccine. The vaccinee reportedly received an injection of hep b vaccine in 1990. It was not known if he had received prior injections of hep B vaccine. An unspecified time post immunization, he reportedly developed Ramsay Hunt syndrome. Outcome of the event was not specified.
pt recv vax & f/o feeling dizzy & rigid & passed out & some gurgling sound were heard;ammonia inhalent applied & pt regained consciousness quietly;feet elevated-cool compress on forehead;
Began having Frequent UTI?s and a constant bladder spasm yet to be relieved by various medication trials along with vaginal pain and discomfort as well as bowel pain; constipation; and difficult passing bowels ?- it has been 7months and have seen various health providers to assist in looking into the matter (urology, colorectal)   Have had ultrasounds, xrays, ruled out kidney stones, have tried 3 trials of medications to assist with symptoms in addition to 4 rounds of antibiotics (1 the first infection) and (3 for the last infection); relieves UTI but not the symptoms. Am now scheduled for additional colorectal consult and colonoscopy.   Have had increased heart rate and low blood pressure - now am wearing an EKG holter to further monitor and determine appropriate course to assist with symptoms.  Migraines have returned.   It does not appear I am having a relapse of MS due to no enhanced or new lesions, but these issues can be a natural course  of MS and related to nerve issues;   while I had POTS already from a previous massive bilateral pulmonary embolism ? it is not clear if these heart related/blood pressure related symptoms are increasing for any other reason, or just the natural course   I do not and did not automatically assume these issues were related to the vaccine, and no one has told me it was or mentioned this beyond asking if I have had it (everyone asks automatically to enter a dr?s office). I was asked by CDC to fill out this report based on my report on the text sent to me if I had recent medical issues which I said ?yes? but I did NOT answer ?yes? to beLieving it was related to vaccine.
I have had tinnitus for many years at a low level. Since the last vaccination in December, my tinnitus has become more severe. My doctor has told me that there is no treatment.
This spontaneous report was received from a healthcare worker regarding a 61 year old female patient. On 11-SEP-2012, the patient was vaccinated with 0.65 ml ZOSTAVAX subcutaneous injection, lot # (0240AE), expiration date 15-MAR-2013. Concomitant medications were not reported. On 17-SEP-2012, the patient was redness around the eyes and a skin rash. It was reported at this appointment she also complained of redness and swelling at the ZOSTAVAX injection site. There was no treatment given for the events. The outcome of the events were unknown. The patient sought unspecified medical attention (through an office visit). Additional information has been requested.
On 3/13/01, received phone call from mom who reported that there is an area of erythema approx. half dollar-sized, hard and seems about 1/2" away from injection site.
The pt had received 4 mos vaccine at health department. We called HD twice to check on vaccine and was told pt had only had 2 mos vaccine. Pt was given 4 mos vaccine again by family care clinic.
The patient developed unspecified swelling at the injection site; This spontaneous report was received from a registered nurse regarding a 70 years old female patient. The patient's concurrent conditions included hypertension, migraine and cataract. The patient had no concomitant medications and no drug reactions/allergies.  On 12-SEP-2019, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot # S021740, expiration date: 25-MAR-2021, dose and unit not reported) intramuscularly for prophylaxis.  On 13-SEP-2019, the patient developed unspecified swelling at the injection site and was treated by the physician with diphenhydramine hydrochloride (BENADRYL) 25 mg intramuscularly and diphenhydramine hydrochloride (BENADRYL) 25 mg by mouth when necessary. No lab diagnostics/studies were performed. The outcome of the event was not recovered.   The causality assessment between pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) and the event was not provided.
PATIENT FELT DIZZY AFTER FLU VACCINE.  HE WAITED FOR 30 MIN IN WAITING AREA AND THEN FELT BETTER
Patient indicated on 2/1/21 that she has had continued pain in her left arm with movement post vaccination. Her ability to move her left arm is limited to forward and backwards. Cannot lift upwards easily or to the side.  Has an appointment with MD office to confirm diagnosis is related to the vaccine.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not provided. On 03-MAY-2016, the patient was intramuscularly vaccinated with the first dose of PNEUMOVAX23 (dose was not reported) in pneumococcal prevention process. The second dose PNEUMOVAX23 was administered on 08-MAY-2017 (dose was unknown, lot# reported as N001007 expiration date: 19-SEP-2018). Concomitant medications were not reported. No adverse effects reported (also reported as "patient was fine"). Additional information has been requested.
extreme body aches and fever aprox 24 hours after vaccine, lasting aprox 24 hours
pt says she started having pain all over her body.  The pain from her knees down to her feet was horrible.  The left arm hurts and has tingling numb feeling in the hand.  She gets episodes of being light headed and SOB.  She gets sharp pains in her head like something is pinching her on the inside of the brain and is a very strange feeling.  She went to see her PCP about 10 days after taking vaccine and  was referred to a Neurologist Dr.  She was told it looked like nerve inflammation and was prescribed Neurontin.  The medicine helps but has side effects and makes her feel bad.  She has a FU appt next week.
The same day as I received the shot I had a red patch on my arm that was raised and warm. Over the next 2 days the red patch has grown to roughly 4? in diameter. It feels very stiff.
Systemic: Nausea-Medium, Systemic: Fainting-Severe, Systemic: Other- After 2nd dose of covid-19, Patient reported tingling, blood pressure was 198/102, high pulse, tingling in the arm and hand, chest pain, dizzyness
L upper arm W/3-4 inch oral shaped erythematous lesion, warm to touch, slightly raised and mildly tender to palpation, no streaking, no induration, no fluctuance
The morning after the vaccination I began feeling fuzzy headed.  As the day progressed I developed a mild fever, chills and muscle aches similar to a severe flu throughout my body (arms, legs, back).  This lasted through the night and into the next day, slowly subsiding from mid-day of the second day fading to only general weakness the second evening (48 hours after the vaccination).
Expired vaccine used; 0.3 administered as booster; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and ACCIDENTAL OVERDOSE (0.3 administered as booster) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 034C21A, 030B21A and 046A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 08-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .3 milliliter. On 08-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). 08-Dec-2021, the patient experienced ACCIDENTAL OVERDOSE (0.3 administered as booster). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and ACCIDENTAL OVERDOSE (0.3 administered as booster) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) to be not related. No further causality assessment was provided for ACCIDENTAL OVERDOSE (0.3 administered as booster).    No concomitant medications were provided. No treatment medications were provided. Expired vaccine was given with no adverse reaction.
Swelling to left thigh and redness 9 1/2 cm x 5 cm
Moderna vaccine given more than 6 hours after first vial puncture; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine given more than 6 hours after first vial puncture) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine given more than 6 hours after first vial puncture). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine given more than 6 hours after first vial puncture) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.  Pharmacist called to report 5 patients were given Moderna vaccine more than 6 hours after first vial puncture.
Patient was given the second dose of the Moderna shot a week prior to when she was due.  Patient reported on July 23, 2021 that she had aching, fever of 101.8, swollen arm, head cold, eye pressure, high blood sugar levels and diarrhea.
Extreme joint pain in all joints. Stiffness in all joints. Difficulty walking. Chills. Muscle cramps. Diarrhea. Extreme fatigue. Joint pain was so excruciating it was difficult to even walk. Lasted approx. 14 hours.
Swollen glands near her ear and on her neck; Rash that was red at the top of her face near her ear; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH ERYTHEMATOUS (Rash that was red at the top of her face near her ear) and LYMPHADENOPATHY (Swollen glands near her ear and on her neck) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concomitant products included METFORMIN, OLMESARTAN MEDOXOMIL, ROSUVASTATIN, DILTIAZEM, SITAGLIPTIN and COLECALCIFEROL (VITAMIN D 3) for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Rash that was red at the top of her face near her ear). On 14-Feb-2021, the patient experienced LYMPHADENOPATHY (Swollen glands near her ear and on her neck). At the time of the report, RASH ERYTHEMATOUS (Rash that was red at the top of her face near her ear) and LYMPHADENOPATHY (Swollen glands near her ear and on her neck) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment for the event included cipro-dexamethasone ear drops. azithromycin.  Patient took a steroid shot (doesn't know the name) on January 26th.   Most recent FOLLOW-UP information incorporated above includes: On 24-Apr-2021: Reporter contact information added.Patient demographics added On 26-Apr-2021: Email address updated (No New information) On 12-May-2021: Non significant follow-up appended into AER MOD-2021-014849
diarrhea; nausea; Arm would only move 30 degrees up; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150), via an unspecified route of administration in the left arm on 02Apr2021 (at the age of 22-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported and the patient had a history of allergy to peanuts. Concomitant medication included birth control (MANUFACTURER UNKNOWN) taken within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021, on day of shot the patient was able to move arm only 30 degrees up. On 03Apr2021 i.e., on Saturday night, the patient experienced diarrhea and nausea and again on Monday all day. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutics measures were not taken as a result of the events. The clinical outcome of the events diarrhea, nausea and arm would only move 30 degrees up were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Information has been received from a 19 year old female consumer, for GARDASIL a Pregnancy Registry product, with no drug reactions/allergies and a history of breaking her arm twice who in approximately 2007 was vaccinated with the first dose of GARDASIL (Lot# and route not reported) and the second dose of GARDASIL (Lot# and route not reported) while she was pregnant. There was no concomitant medication. The patient stated that in approximately 2007 (about 5 years ago) she received the first GARDASIL injection and experienced some redness and swelling at the injection site. After receiving the second injection of the GARDASIL she realized that she had received the product while she was pregnant. The patient did not remember the dates she received either GARDASIL injection. The patient sought unspecified medical attention. No treatment was given. The patient's pregnancy had been confirmed by pregnancy test. Her last LMP was on 17-NOV-2011. Expected date of delivery was 23-AUG-2012. At the time of the report, the patient had not recovered yet. Follow up information was received from a Registered Nurse on 27-FEB-2014. The reporter stated that the patient had a miscarriage. The patient was still at the practice. Upon internal review, spontaneous abortion was considered to be medically significant event. Additional information is not expected.
HSP (Henoch Schonlein Purpura); admitted to hospital because of painful purpura, fever and abdominal pain with emesis.
Within one hour of Varicella vaccine administration patient developed injected eyes and periorbital edema. Presumed to clinic with bilateral conjunctivitis infected, periorbital area puffy. Vital signs WNL. Benadryl 1 tsp PO given.
unusual extend of swelling of entire upper arm; pain extended into axillae;scapulae & pectoralis on same side;
I contracted shingles, zoster virus. I've read that the vaccine can reactivate this chickenpox virus, which usually affects older people. I state that I am a sportsman and the virus hit me during a period of high sporting stress. But I doubted, being young that there could also be a correlation with the vaccine.
Suspected Vaccination failure; three years later, I still have symptoms; i may have to resort to a lifetime of gabapentin pills to get relief; I had double vaccination / three years later, I still have symptoms and flare ups; I may have to resort to a lifetime of gabapentin pills to get relief; Suspected vaccination failure; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.  Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis and Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine, the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On 27th April 2018, less than a year after receiving Shingles vaccine and not applicable after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. The patient was treated with gabapentin. On an unknown date, the outcome of the vaccination failure, vaccination failure, shingles and pain were unknown and the outcome of the shingles and pain were recovered/resolved.   It was unknown if the reporter considered the vaccination failure, vaccination failure, shingles, pain, shingles and pain to be related to Shingles vaccine. It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient herself/himself. The age at vaccination was not reported. The age group was not reported but was captured as adult as per vaccine indication.  The patient received dose of Shingles vaccine previously and the reporter stated that  on 27th April 2018 patient had worst most deep pain and he/she not a complainer and also stated that vaccine was rendered ineffective and patient was in so much pain. The patient also received the two doses of Shingles vaccine later and patient experienced pain and shingles. The reporter stated that as soon as patient was mostly asymptomatic he/she had the double vaccination. The reporter stated that even three years later the patient still had symptoms and flare ups in the shingles location. The reporter stated that he/she might have to resort to a lifetime of gabapentin pills to get relief. The patient advised to people that to get the shingles vaccination. This case was considered as suspected vaccination failure since the time to onset and laboratory test confirming shingles were unknown at the time of reporting.
Dizzy monitored for 30min. Recovered p 20min Hx of dizziness c blood draws